Legal & General Group PLC Satsuma Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.8 - $7.25 $4,305 - $6,503	-897 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.85 - $28.47 $2,375 - $17,565	-617 Reduced 40.75%	897 $3,000
Q2 2020 Aug 14, 2020	BUY	$16.01 - $34.69 $15,513 - $33,614	969 Added 177.8%	1,514 $44,000
Q1 2020 May 14, 2020	SELL	$14.53 - $30.69 $5,303 - $11,201	-365 Reduced 40.11%	545 $11,000
Q4 2019 Feb 13, 2020	BUY	$9.32 - $19.68 $8,481 - $17,908	910 New	910 $18,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.